Afatinib and Temozolomide combination inhibits...

Journal of Experimental & Clinical Cancer Research 2019 / 12 Vol. 38; Iss. 1

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells

Vengoji, Raghupathy, Macha, Muzafar A., Nimmakayala, Rama Krishna, Rachagani, Satyanarayana, Siddiqui, Jawed A., Mallya, Kavita, Gorantla, Santhi, Jain, Maneesh, Ponnusamy, Moorthy P., Batra, Surinder
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
38
Language:
english
Journal:
Journal of Experimental & Clinical Cancer Research
DOI:
10.1186/s13046-019-1264-2
Date:
December, 2019
File:
PDF, 4.48 MB
english, 2019
Conversion to is in progress
Conversion to is failed